News
All NewsPress ReleasesProduct Approvals and Launches
Video
All Video TypesAJMC TVGuidelinesInsightsOnLocationPayer PerspectivesPeer ExchangePost Conference PerspectivesStakeholder Summit
Podcasts
Journals
All JournalsThe American Journal of Managed CarePopulation Health, Equity & OutcomesEvidence-Based OncologyAbout Supplements and Featured PublicationsSupplements and Featured Publications IssuesSubmit a Manuscript
More
Conferences
Conference CoverageConference ListingPost Conference Perspectives
Events
Institute for Value-Based MedicinePatient-Centered Oncology Care
Resources
Interactive ToolsFormulary CentralClinical SpotlightMicrositesSponsored Content
CE
About AJMC
AJMC StaffAnniversarySeema Sonnad AwardStrategic Alliance Partners

Subscribe

  • News
  • Video
  • Podcasts
  • Journals
  • Conferences
  • Events
  • Resources
  • CE
  • About AJMC
  • Subscribe
  • Biosimilars
  • Cardiorenalmetabolic
    • Cardiomyopathy
    • Cardiovascular
    • Chronic Kidney Disease
    • Diabetes
    • Heart Failure
    • Type 1 Diabetes
  • Dermatology
    • Alopecia
    • Atopic Dermatitis
    • Psoriasis
  • Gastroenterology
  • Hematology
    • ALL/AML
    • CLL/SLL
    • GVHD
    • Hemophilia
    • Mantle Cell Lymphoma
    • Multiple Myeloma
    • Myelodysplastic Syndromes
    • Myeloproliferative Neoplasms
    • Non-Hodgkin Lymphoma
    • Rare Blood
  • Hepatology
    • Liver
    • MASH
  • Immunology
    • Allergy
    • Autoimmune
    • Inflammation
    • Lupus
    • Myasthenia Gravis
    • Rheumatoid Arthritis
  • Infectious Disease
    • COVID-19
    • HIV
    • RSV
    • Vaccines
  • Mental Health
    • Major Depressive Disorder
    • Sleep
  • Neurology
    • Duchenne Muscular Dystrophy
    • Epilepsy
    • Multiple Sclerosis
    • Parkinson Disease
  • Obesity
  • Oncology
    • Breast Cancer
    • Cholangiocarcinoma
    • Colorectal Cancer
    • Immuno-Oncology
    • Liver Cancer
    • Non–Small Cell Lung Cancer
    • Ovarian Cancer
    • Prostate Cancer
    • Skin Cancer
    • Small Cell Lung Cancer
    • Soft Tissue Sarcoma
  • Ophthalmology
  • Pulmonology
    • COPD
    • Pulmonary Arterial Hypertension
  • Rare Disease
    • Spinal Muscular Atrophy
  • Respiratory
    • Asthma
    • Pulmonary Fibrosis
  • Rheumatology
  • Women's Health
  • Biosimilars
  • Center on Health Equity & Access
  • Digital Health
  • Formulary
  • Gene Therapy
  • Guidelines
  • Health Care Administration
    • Employers
    • Medicare
    • Reimbursement
  • Health Care Cost
  • Health Care Delivery
  • Insurance
  • Policy
  • Population Health
  • Product Approvals and Launches
  • Technology
  • Value-Based Care
Spotlight -
Free In-Person Regional Events Focused on Oncology and Population Health
Advertisement

Gary E. Meininger, MD

Advertisement

Articles by Gary E. Meininger, MD

Diabetes-Related Quality Measure Attainment: Canagliflozin Versus Sitagliptin Based on a Pooled Analysis of 2 Clinical Trials

ByRobert A. Bailey, MD,Ujjwala Vijapurkar, PhD,Gary E. Meininger, MD,Marcia F. T. Rupnow, PhD,Lawrence Blonde, MD
December 16th 2014

Participating Faculty: Diabetes-Related Quality Measure Attainment: Canagliflozin Versus Sitagliptin Based on a Pooled Analysis of 2 Clinical Trials

ByRobert A. Bailey, MD,Ujjwala Vijapurkar, PhD,Gary E. Meininger, MD,Marcia F.T. Rupnow, PhD,Lawrence Blonde, MD
December 15th 2014

Attainment of Diabetes-Related Quality Measures With Canagliflozin Versus Sitagliptin

ByRobert A. Bailey, MD,C. V. Damaraju, PhD,Silas C. Martin, MS,Gary E. Meininger, MD,Marcia F. T. Rupnow, PhD,Lawrence Blonde, MD
January 25th 2014
Advertisement

Latest Updated Articles

  • Participating Faculty: Diabetes-Related Quality Measure Attainment: Canagliflozin Versus Sitagliptin Based on a Pooled Analysis of 2 Clinical Trials
    Participating Faculty: Diabetes-Related Quality Measure Attainment: Canagliflozin Versus Sitagliptin Based on a Pooled Analysis of 2 Clinical Trials

    Published: December 15th 2014 | Updated:

  • Diabetes-Related Quality Measure Attainment: Canagliflozin Versus Sitagliptin Based on a Pooled Analysis of 2 Clinical Trials
    Diabetes-Related Quality Measure Attainment: Canagliflozin Versus Sitagliptin Based on a Pooled Analysis of 2 Clinical Trials

    Published: December 16th 2014 | Updated:

  • Attainment of Diabetes-Related Quality Measures With Canagliflozin Versus Sitagliptin
    Attainment of Diabetes-Related Quality Measures With Canagliflozin Versus Sitagliptin

    Published: January 25th 2014 | Updated:



Advertisement
Advertisement

Trending on AJMC

1

New Legislation Aims to Address Transparency in PBMs as First Major Step in Reform

2

Catchment Areas Shape Diversity and Access in Oncology Trials: Amir Fathi, MD

3

Advances in MASLD and MASH Care Highlight Progress and Persistent Gaps

4

Medicare’s 3-Day Rule Reinstatement Lengthened Hospital Stays Without Cost, Outcome Benefits

5

Overcoming Mistrust in Clinical Trial Enrollment Through Community Resources: Susan Vadaparampil, PhD, MPH

Brand Logo
  • About
  • Contact
  • Editorial Boards
  • Advertise
  • Do Not Sell My Information
  • Terms & Conditions
  • Privacy Policy

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

609-716-7777

© 2025 MJH Life Sciences®

All rights reserved.

Secondary Brand Logo
Alt TextAlt Text